ventricular tachycardia was evaluated by 24-h ambulatory ECG monitoring.
Quantitative Polymerase Chain Reaction (PCR) of Cytokine mRNA
Heart tissue specimens from 6 patients with cardiac sarcoidosis (cases S1, S3, S4, S5, S6 and S12) and 10 agematched DCM patients were large enough for RNA extraction.
Cytokine mRNA expression was measured by real time quantitative reverse transcriptase-PCR method, using the ABI Prism 7700 sequence detection system (Perkin-Elmer Applied Biosystems, Shelton, CT, USA). 4 cDNA was synthesized from 100 ng of total RNA. Relative quantification and standardization were achieved using a log 10 dilution series of RNA extracted from a rat spleen (calibrator). Relative quantification of 18S ribosomal, interleukin (IL)-1 , IL-1 , IL-2, IL-4, IL-5, IL-8, IL-10, IL-12 p35, IL-12 p40, IL-15, interferon (IFN)-and tumor necrosis factor (TNF)-mRNA was calculated by the comparative cycle threshold method provided by Perkin-Elmer. 5 Because the values for the calibrator wells are always subtracted from themselves, their relative quantification values (cytokine gene/18S ribosomal gene) are calculated as 1. This method has been applied in our previous studies, is proven to be reliable, and is described in detail elsewhere. 6, 7 
Histopathological and Immunohistochemical Examinations
Each specimen was embedded in paraffin and sections were stained with hematoxylin -eosin for observation under a light microscope. Mouse monoclonal antibodies against human IL-12 and IFN-(R&D Systems, Inc, Minneapolis, MN, USA) were used to identify inflammatory cytokines. Mouse monoclonal antibodies against CD45 (a marker for lymphocytes) and CD68 (a marker for macrophages) (DAKO Japan, Japan) were used to identify the types of infiltrating inflammatory cells. The immunoreactivity was examined using the avidinbiotin -peroxidase complex method (ScyTek Laboratories, Logan, UT, USA). Finally, the reactions were optimized with diaminobenzidine chromogen and counterstained with hematoxylin.
Statistical Analysis
Data are expressed as means ±SD for continuous variables, and as numbers (percentages) for categorical variables. Expression of cytokine mRNA was compared between patients with cardiac sarcoidosis and those with DCM by Mann-Whitney analysis. A p-value <0.05 was considered statistically significant.
Results

Clinical Information
Between the DCM and cardiac sarcoidosis groups, statistical differences were observed in medication of spironolactone, the existence of advanced atrioventricular block, and the left ventricular end-diastolic and end-systolic diameters (Table 2) .
General Histological Appearance
Large, typical non-caseating sarcoid granulomas were observed in sections from all sarcoidosis patients. They were mainly composed of lymphocytes, macrophages, multinucleated giant cells, and interstitial components. Cardiomyocytes adjacent to the sarcoid granulomas were occasionally found to be degenerative or necrotic (Figs 1a,b) . Lymphocytes were mostly positive for CD45, whereas macrophages and giant cells were positive for CD68.
In the DCM hearts, severe to moderate interstitial fibrosis and fatty infiltration were generally observed. Adjacent to interstitial fibrosis, the cardiomyocytes occasionally ex- 
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hibited cytoplasmic vacuolization, scarcity of myofibrils, atrophy or hypertrophy and nuclear alterations.
Quantitative PCR of Cytokine mRNA
The expression of the mRNA each of IL-1 , IL-2, IL-12 p40, and IFN-was specifically enhanced in the myocardium from patients with cardiac sarcoidosis (Table 3 ). The expression levels of IL-1 (p=0.035), IL-2 (p=0.001), IL12p40 (p=0.001), IL-15 (p=0.039), and IFN-(p<0.001) were significantly different between cardiac sarcoidosis and DCM. The ratio of positivity for each of these cytokines was significantly higher in the sarcoid group than in the DCM group. The expression of IL-1 , IL-8, IL-10, IL-15, and TNF-mRNA was observed in the myocardium of both cardiac sarcoidosis and DCM; however, the expression tended to be higher in the sarcoid myocardium. Neither IL-4 nor IL-5 was detectable in the myocardium from both diseases.
Immunohistochemistry of Inflammatory Cytokines
In the myocardium of sarcoidosis patients, IL-12 was strongly positive in the cytoplasm of multinucleated giant cells and macrophages in the granulomas (Figs 1c,d ). Positive staining for IFN-was observed in lymphocytes and vascular endothelial cells (data not shown). Cytokine expression was limited to areas with well-formed, active granulomas. DCM hearts, on the other hand, did not show positive staining of either IL-12 or IFN-, even in the area of focal inflammatory cell infiltrates with lymphocytes and macrophages.
Discussion
Recent studies have demonstrated the significance of the expression of inflammatory cytokines in the pathogenesis of sarcoidosis. 3, 8 Moller et al described sarcoidosis as an antigen-driven type 1 helper T-cell (Th1) mediated delayedtype hypersensitivity dominated by expression of IL-12 and IFN-. 3, 9 Preferential expression of Th1 cytokines has been reported in bronchoalveolar lavage cells and fluids from patients with pulmonary sarcoidosis. [9] [10] [11] In the present study, we have demonstrated for the first time enhanced expression of Th1 cytokine mRNAs in the myocardium of patients with active cardiac sarcoidosis. It is not easy to confirm the diagnosis of cardiac sarcoidosis, particularly when there is not definite extra-cardiac involvement. Furthermore, in the course of disease progression, it is often difficult to distinguish it from DCM. In fact, as shown in this study, the diagnosis of cardiac sarcoidosis is occasionally missed, even in Japan where the condition appears to be relatively prevalent. 12, 13 Most diagnostic tests, including endomyocardial biopsy, 14 have low sensitivity, low specificity or both. The most accurate diagnostic strategy is currently unknown, so a valuable diagnostic marker would be extremely useful and is anticipated.
In the present study, because IL-12 and INF-expression was limited to areas with well-formed, active non-caseating granulomas in the myocardium, enhanced expression of these cytokines could contribute either to the diagnosis of cardiac involvement of sarcoidosis or to an estimate of disease activity. 15 It has been recently reported that circulating IL-12 p40 is increased in sarcoidosis patients and is particularly correlated with the number of involved organs, which reflects systemic disease expansion. Additionally, mRNA expression of IL-12 p40 was increased in sarcoid lymph nodes. 16 It should be noted that enhanced expression of Th1 cytokines is not specific for the heart.
Study Limitations
As shown in Table 1 , most sarcoidosis patients included in the present study had not been suspected as having cardiac sarcoidosis and were first diagnosed after cardiac surgery or at autopsy. Thus, we had a small number of sarcoidosis patients who had sufficient clinical information concerning cardiac sarcoidosis and consequently, evaluation of the relationship between myocardial cytokine expression and clinical data indicating severity or activity of cardiac sarcoidosis, such as using 67 Ga or 201 Tl scintigraphy, magnetic resonance imaging, and serum levels of angiotensin-converting enzyme or lysozyme, was not conducted satisfactorily. Future study including the measurement of peripheral blood cytokine levels is warranted to examine whether Th1 cytokine expression in the myocardium reflects disease severity or activity in patients with cardiac sarcoidosis.
Conclusions
Th1 cytokines may be involved in the pathogenesis of cardiac sarcoidosis. The findings of the present study support the potential of Th1 cytokines in diagnosing cardiac sarcoidosis and estimating disease activity.
